Reaction Details Report a problem with these data
Target
Mitogen-activated protein kinase 1
Ligand
BDBM180936
Substrate
n/a
Meas. Tech.
Enzymatic Assay
pH
7.3±n/a
IC50
1.1±n/a nM
Comments
extracted
Citation
Blake, JF; Chen, H; Chicarelli, MJ; Demeese, J; Garrey, R; Gaudino, JJ; Kaus, RJ; Kolakowski, GR; Marlow, AL; Mohr, PJ; Ren, L; Schwarz, J; Siedem, CS; Thomas, AA; Wallace, E; Wenglowsky, SM; Boyd, S Serine/threonine kinase inhibitors US Patent US9133187 Publication Date 9/15/2015
More Info.:
Target
Name:
Mitogen-activated protein kinase 1
Synonyms:
ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK
Type:
Ser/Thr Protein Kinase
Mol. Mass.:
41392.76
Organism:
Human
Description:
P28482
Residue:
360
Sequence:
MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS